'Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015', provides an overview of the Multiple Myeloma (Kahler's Disease)'s therapeutic pipeline.
Company profiles mentioned in this report are Adaptimmune Limited, Aptose Biosciences Inc., Astex Pharmaceuticals, Inc., Cellectar Biosciences, Inc., Celleron Therapeutics Limited, Hutchison MediPharma Limited, Immunomic Therapeutics, Inc., Karyopharm Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Oncolytics Biotech Inc., Panacela Labs, Inc., Quest PharmaTech Inc., Threshold Pharmaceuticals, Inc., Xencor, Inc., XTL Biopharmaceuticals Ltd., Zyngenia, Inc.
This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler's Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Multiple Myeloma (Kahler's Disease) and special features on late-stage and discontinued projects.
Report: www.rnrmarketresearch.com/contact…ame=403535 . (This is a premium report price at US$2500 for a single user PDF license)
Scope
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report summarizes all the dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Multiple Myeloma (Kahler's Disease) pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
For more information:
News From
RnR Market Research Category: Industry Reports & Market Analysis Profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
